AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 36693686 — intervention group
Group type: EXPERIMENTAL
Intervention: Most recent hamstring IMI >12 months but <3 years prior to PHE
Number of subjects: 134
Study 36693686 — intervention group
Group type: EXPERIMENTAL
Intervention: Age (per 1-year increase)
Number of subjects: 134
Study 36693686 — intervention group
Group type: EXPERIMENTAL
Intervention: Most recent previous hamstring IMI >12 months but <3 years prior to PHE (multivariable analysis)
Number of subjects: 134
Study 36693686 — intervention group
Group type: EXPERIMENTAL
Intervention: Age (multivariable analysis, per 1-year increase)
Number of subjects: 134
Study 36693691 — intervention group
Group type: EXPERIMENTAL
Intervention: Live group (seated, virtual exercise programme via Zoom)
Number of subjects: 60
Study 36693691 — intervention group
Group type: COMPARATOR
Intervention: Prercorded group (exercise using prerecorded videos)
Number of subjects: 60
Study 36693722 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower estimated glomerular filtration rate (eGFR)
Number of subjects: 3033
Study 36693722 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive function assessment using Mini-Mental State Examination (MMSE)
Number of subjects: 3033
Study 36693722 — intervention group
Group type: EXPERIMENTAL
Intervention: Cox proportional hazard model for incident cognitive outcome
Number of subjects: 3033
Study 36693773 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone mouthwash (preventive)
Number of subjects: 39
Study 36693773 — intervention group
Group type: COMPARATOR
Intervention: Placebo mouthwash (therapeutic)
Number of subjects: 39
Study 36693948 — intervention group
Group type: EXPERIMENTAL
Intervention: Energy device for mesoappendix transection
Number of subjects: 3768
Study 36693948 — intervention group
Group type: COMPARATOR
Intervention: Electrocautery for mesoappendix transection
Number of subjects: 3768
Study 36693948 — intervention group
Group type: COMPARATOR
Intervention: Looped ligatures for appendix resection
Number of subjects: 3768
Study 36693948 — intervention group
Group type: COMPARATOR
Intervention: Stapler for appendix resection
Number of subjects: 3768
Study 36693948 — intervention group
Group type: COMPARATOR
Intervention: Clips for appendix resection
Number of subjects: 3768
Study 36693978 — intervention group
Group type: EXPERIMENTAL
Intervention: Recruitment maneuver
Number of subjects: 20
Study 36693978 — intervention group
Group type: EXPERIMENTAL
Intervention: Prone positioning
Number of subjects: 20
Study 36693978 — intervention group
Group type: COMPARATOR
Intervention: Supine position
Number of subjects: 20
Study 36693978 — intervention group
Group type: EXPERIMENTAL
Intervention: Prone position
Number of subjects: 20
Study 36694110 — intervention group
Group type: EXPERIMENTAL
Intervention: Multidisciplinary approach to evaluate post-COVID-19 conditions (PCC)
Number of subjects: 361
Study 36694217 — intervention group
Group type: EXPERIMENTAL
Intervention: Conscious connected breathing with breath retention intervention
Number of subjects: 24
Study 36694217 — intervention group
Group type: COMPARATOR
Intervention: Deep breathing sham control intervention
Number of subjects: 24
Study 36694232 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical pharmacy services (PharmaCAP trial intervention)
Number of subjects: 0
Study 36694232 — intervention group
Group type: COMPARATOR
Intervention: Usual standard care (control group)
Number of subjects: 0
Study 36694238 — intervention group
Group type: EXPERIMENTAL
Intervention: Mechanical ventilation
Number of subjects: 630
Study 36694238 — intervention group
Group type: EXPERIMENTAL
Intervention: Diabetes
Number of subjects: 630
Study 36694238 — intervention group
Group type: EXPERIMENTAL
Intervention: GCS < 8
Number of subjects: 630
Study 36694238 — intervention group
Group type: EXPERIMENTAL
Intervention: Night time admission
Number of subjects: 630
Study 36694361 — intervention group
Group type: EXPERIMENTAL
Intervention: Sofosbuvir/Velpatasvir for 12 weeks
Number of subjects: 400
Study 36694376 — intervention group
Group type: EXPERIMENTAL
Intervention: In-person ILI delivered by nutrition interns
Number of subjects: 268
Study 36694613 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous immunoglobulin (IVIG) followed by steroids
Number of subjects: 0
Study 36694613 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous immunoglobulin (IVIG) followed by anakinra
Number of subjects: 0
Study 36694613 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous immunoglobulin (IVIG) followed by infliximab
Number of subjects: 0
Study 36694918 — intervention group
Group type: EXPERIMENTAL
Intervention: Culturally adapted telephone genetic counseling protocol and visual aid booklet
Number of subjects: 14
Study 36694943 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcranial magnetic resonance-guided focused ultrasound (MRgFUS)
Number of subjects: 9
Study 36695071 — intervention group
Group type: EXPERIMENTAL
Intervention: Aβ-PET in regions of WMH
Number of subjects: 115
Study 36695071 — intervention group
Group type: EXPERIMENTAL
Intervention: Aβ-PET in normal-appearing WM
Number of subjects: 115
Study 36695071 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive impairment
Number of subjects: 115
Study 36695286 — intervention group
Group type: EXPERIMENTAL
Intervention: Spinal manipulation
Number of subjects: 60
Study 36695286 — intervention group
Group type: COMPARATOR
Intervention: Sham manipulation
Number of subjects: 60
Study 36695286 — intervention group
Group type: COMPARATOR
Intervention: Control (pharmacological therapy only)
Number of subjects: 60
Study 36695297 — intervention group
Group type: EXPERIMENTAL
Intervention: Full Support (with support from quality improvement expert)
Number of subjects: 24
Study 36695297 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-Guided (using only online materials)
Number of subjects: 24
Study 36695297 — intervention group
Group type: COMPARATOR
Intervention: Usual Care (nonrandomized control arm)
Number of subjects: 24
Study 36695299 — intervention group
Group type: EXPERIMENTAL
Intervention: Obesity clinic group (BMI >90th percentile)
Number of subjects: 3854
Study 36695299 — intervention group
Group type: COMPARATOR
Intervention: Population-based group
Number of subjects: 3854
Study 36695307 — intervention group
Group type: EXPERIMENTAL
Intervention: Cardiac diastolic dysfunction
Number of subjects: 330
Study 36695307 — intervention group
Group type: EXPERIMENTAL
Intervention: Overt coronary microvascular dysfunction (CMD)
Number of subjects: 330
Study 36695307 — intervention group
Group type: EXPERIMENTAL
Intervention: Overt CMD
Number of subjects: 330
Study 36695396 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermediate-dose LMWH
Number of subjects: 1110
Study 36695396 — intervention group
Group type: COMPARATOR
Intervention: Low-dose LMWH
Number of subjects: 1110
Study 36695397 — intervention group
Group type: EXPERIMENTAL
Intervention: Computed tomography pulmonary angiography (CTPA)
Number of subjects: 417
Study 36695397 — intervention group
Group type: COMPARATOR
Intervention: Low clinical probability and normal D-dimer
Number of subjects: 417
Study 36695397 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients without other findings suspicious for PE
Number of subjects: 417
Study 36695397 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with findings suspicious for PE
Number of subjects: 417
Study 36695416 — intervention group
Group type: EXPERIMENTAL
Intervention: upright-backward
Number of subjects: 32
Study 36695416 — intervention group
Group type: COMPARATOR
Intervention: upright-forward
Number of subjects: 32
Study 36695416 — intervention group
Group type: EXPERIMENTAL
Intervention: wheelie-forward
Number of subjects: 32
Study 36695416 — intervention group
Group type: EXPERIMENTAL
Intervention: wheelie-backward
Number of subjects: 32
Study 36695483 — intervention group
Group type: EXPERIMENTAL
Intervention: Remdesivir
Number of subjects: 11218
Study 36695625 — intervention group
Group type: EXPERIMENTAL
Intervention: ATG monotherapy (6 or 3 mg/kg body weight) without concomitant immunosuppression
Number of subjects: 6
Study 36695682 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose cholecalciferol (100,000 IU every 2 weeks for 2 months, then monthly for 22 months)
Number of subjects: 536
Study 36695682 — intervention group
Group type: COMPARATOR
Intervention: Low-dose cholecalciferol (12,000 IU every 2 weeks for 2 months, then monthly for 22 months)
Number of subjects: 536
Study 36695682 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose cholecalciferol
Number of subjects: 536
Study 36695682 — intervention group
Group type: COMPARATOR
Intervention: Low-dose cholecalciferol
Number of subjects: 536
Study 36695790 — intervention group
Group type: EXPERIMENTAL
Intervention: Peeled internal limiting membrane reposition
Number of subjects: 27
Study 36695790 — intervention group
Group type: COMPARATOR
Intervention: Traditional internal limiting membrane peeling
Number of subjects: 27
Study 36695802 — intervention group
Group type: EXPERIMENTAL
Intervention: Best-corrected visual acuity
Number of subjects: 38
Study 36695802 — intervention group
Group type: EXPERIMENTAL
Intervention: Metamorphopsia (M-CHARTS)
Number of subjects: 38
Study 36695802 — intervention group
Group type: EXPERIMENTAL
Intervention: Aniseikonia (New Aniseikonia Test)
Number of subjects: 38
Study 36695802 — intervention group
Group type: EXPERIMENTAL
Intervention: Outer retinal fold
Number of subjects: 38
Study 36695802 — intervention group
Group type: EXPERIMENTAL
Intervention: Outer retinal reflectivity
Number of subjects: 38
Study 36695965 — intervention group
Group type: EXPERIMENTAL
Intervention: Crown lengthening surgery (CLS)
Number of subjects: 18
Study 36696167 — intervention group
Group type: EXPERIMENTAL
Intervention: Pictograms
Number of subjects: 57
Study 36696167 — intervention group
Group type: COMPARATOR
Intervention: Control group (no pictograms)
Number of subjects: 57
Study 36696168 — intervention group
Group type: EXPERIMENTAL
Intervention: Mixed intervention (face-to-face-digital) with a checklist integrated into the clinical workflow.
Number of subjects: 22
Study 36696168 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified in detail).
Number of subjects: 22
Study 36696172 — intervention group
Group type: EXPERIMENTAL
Intervention: Accurate step count
Number of subjects: 117
Study 36696172 — intervention group
Group type: COMPARATOR
Intervention: Deflated step count
Number of subjects: 117
Study 36696172 — intervention group
Group type: COMPARATOR
Intervention: Inflated step count
Number of subjects: 117
Study 36696172 — intervention group
Group type: EXPERIMENTAL
Intervention: Accurate step count + meta-mindset intervention
Number of subjects: 117
Study 36696206 — intervention group
Group type: EXPERIMENTAL
Intervention: Caplacizumab
Number of subjects: 232
Study 36696206 — intervention group
Group type: COMPARATOR
Intervention: Control (no caplacizumab)
Number of subjects: 232
Study 36696215 — intervention group
Group type: EXPERIMENTAL
Intervention: individual factor VIII concentrates
Number of subjects: 1076
Study 36696330 — intervention group
Group type: EXPERIMENTAL
Intervention: LYMPHA
Number of subjects: 45
Study 36696330 — intervention group
Group type: COMPARATOR
Intervention: non-LYMPHA
Number of subjects: 45
Study 36696540 — intervention group
Group type: EXPERIMENTAL
Intervention: ibrutinib plus R-CHOP
Number of subjects: 766
Study 36696540 — intervention group
Group type: COMPARATOR
Intervention: R-CHOP
Number of subjects: 766
Study 36696639 — intervention group
Group type: EXPERIMENTAL
Intervention: DHEA-S
Number of subjects: 79
Study 36696639 — intervention group
Group type: EXPERIMENTAL
Intervention: FSH
Number of subjects: 79
Study 36696639 — intervention group
Group type: EXPERIMENTAL
Intervention: WMH
Number of subjects: 79
Study 36696822 — intervention group
Group type: EXPERIMENTAL
Intervention: 4-meter walk test (4-MWT)
Number of subjects: 36
Study 36696822 — intervention group
Group type: COMPARATOR
Intervention: 10-meter walk test (10-MWT)
Number of subjects: 36
Study 36696822 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 times sit-to-stand test (5TSTS)
Number of subjects: 36
Study 36696827 — intervention group
Group type: EXPERIMENTAL
Intervention: Shorter antimicrobial treatment (≤10 days)
Number of subjects: 382
Study 36696827 — intervention group
Group type: COMPARATOR
Intervention: Longer antimicrobial treatment (>10 days)
Number of subjects: 382
Study 36696827 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall median duration of antibiotic therapy
Number of subjects: 382
Study 36696826 — intervention group
Group type: EXPERIMENTAL
Intervention: Infants with 'Never recovered' growth trajectory
Number of subjects: 0
Study 36696826 — intervention group
Group type: EXPERIMENTAL
Intervention: Infants with 'Partially recovered' growth trajectory
Number of subjects: 0
Study 36696826 — intervention group
Group type: EXPERIMENTAL
Intervention: Parents with low dyadic adjustment and infants with 'Partially recovered' growth trajectory
Number of subjects: 0
Study 36696826 — intervention group
Group type: EXPERIMENTAL
Intervention: Parents with high dyadic adjustment and infants with 'Never recovered' growth trajectory
Number of subjects: 0
Study 36696826 — intervention group
Group type: EXPERIMENTAL
Intervention: Quality of partner relationship
Number of subjects: 0
Study 36696843 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-report of drug use
Number of subjects: 295
Study 36696843 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-report of drug use among those with positive opioid UDS
Number of subjects: 295
Study 36696843 — intervention group
Group type: COMPARATOR
Intervention: Treatment type
Number of subjects: 295
Study 36696980 — intervention group
Group type: EXPERIMENTAL
Intervention: Simple hysterectomy
Number of subjects: 40
Study 36696980 — intervention group
Group type: COMPARATOR
Intervention: Modified radical hysterectomy (Querleu-Morrow type B2)
Number of subjects: 40
Study 36696990 — intervention group
Group type: EXPERIMENTAL
Intervention: Favourable lifestyle group (4-6 healthy lifestyle factors)
Number of subjects: 29072
Study 36696990 — intervention group
Group type: EXPERIMENTAL
Intervention: Average lifestyle group (2-3 healthy lifestyle factors)
Number of subjects: 29072
Study 36696990 — intervention group
Group type: EXPERIMENTAL
Intervention: Favourable lifestyle group (non-APOE ε4 carriers)
Number of subjects: 29072
Study 36696990 — intervention group
Group type: EXPERIMENTAL
Intervention: Average lifestyle group (non-APOE ε4 carriers)
Number of subjects: 29072
Study 36696990 — intervention group
Group type: COMPARATOR
Intervention: APOE ε4 status and lifestyle profiles
Number of subjects: 29072
Study 36697048 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioural economics-based incentives and text messages to support medication adherence
Number of subjects: 60
Study 36697048 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 60
Study 36697050 — intervention group
Group type: EXPERIMENTAL
Intervention: Language-supported group antenatal care (gANC)
Number of subjects: 145
Study 36697050 — intervention group
Group type: COMPARATOR
Intervention: Standard antenatal care (sANC)
Number of subjects: 145
Study 36697053 — intervention group
Group type: EXPERIMENTAL
Intervention: VR-BF (biofeedback-based virtual reality) using the ForeVR VR platform to engage breathing in gamified VR applications.
Number of subjects: 70
Study 36697053 — intervention group
Group type: COMPARATOR
Intervention: Control group using a pain reflection app.
Number of subjects: 70
Study 36697134 — intervention group
Group type: EXPERIMENTAL
Intervention: Somatostatin receptor 2 (SST2) PET/MR imaging
Number of subjects: 61
Study 36697156 — intervention group
Group type: EXPERIMENTAL
Intervention: In-hospital persistent AKI
Number of subjects: 8201
Study 36697156 — intervention group
Group type: EXPERIMENTAL
Intervention: Transient AKI
Number of subjects: 8201
Study 36697156 — intervention group
Group type: COMPARATOR
Intervention: No AKI
Number of subjects: 8201
Study 36697158 — intervention group
Group type: EXPERIMENTAL
Intervention: Initial invasive strategy
Number of subjects: 777
Study 36697158 — intervention group
Group type: COMPARATOR
Intervention: Conservative strategy
Number of subjects: 777
Study 36697204 — intervention group
Group type: EXPERIMENTAL
Intervention: Amulet occluder (dual occlusive mechanism device)
Number of subjects: 1788
Study 36697204 — intervention group
Group type: COMPARATOR
Intervention: Watchman device (single occlusive mechanism device)
Number of subjects: 1788
Study 36697204 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with DRT
Number of subjects: 1788
Study 36697207 — intervention group
Group type: EXPERIMENTAL
Intervention: JNJ-56136379 75 mg + nucleos(t)ide analogue (NA)
Number of subjects: 232
Study 36697207 — intervention group
Group type: EXPERIMENTAL
Intervention: JNJ-56136379 250 mg + nucleos(t)ide analogue (NA)
Number of subjects: 232
Study 36697207 — intervention group
Group type: COMPARATOR
Intervention: Placebo + nucleos(t)ide analogue (NA)
Number of subjects: 232
Study 36697207 — intervention group
Group type: EXPERIMENTAL
Intervention: JNJ-56136379 + nucleos(t)ide analogue (NA)
Number of subjects: 232
Study 36697215 — intervention group
Group type: EXPERIMENTAL
Intervention: Multidisciplinary rehabilitation (MR) consisting of a diagnostic multidisciplinary consultation and eight sessions of physical and occupational therapy.
Number of subjects: 47
Study 36697215 — intervention group
Group type: COMPARATOR
Intervention: Usual care (UC)
Number of subjects: 47
Study 36697272 — intervention group
Group type: EXPERIMENTAL
Intervention: Orientation group (n=57)
Number of subjects: 114
Study 36697272 — intervention group
Group type: COMPARATOR
Intervention: Control group (n=57)
Number of subjects: 114
Study 36697317 — intervention group
Group type: EXPERIMENTAL
Intervention: Ipatasertib plus abiraterone
Number of subjects: 1097
Study 36697317 — intervention group
Group type: COMPARATOR
Intervention: Placebo plus abiraterone
Number of subjects: 1097
Study 36697694 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment of maternal periodontal disease during pregnancy
Number of subjects: 306
Study 36697694 — intervention group
Group type: COMPARATOR
Intervention: Control group (treatment after pregnancy)
Number of subjects: 306
Study 36697840 — intervention group
Group type: EXPERIMENTAL
Intervention: Bifidobacterium animalis subsp. lactis DN-173010 containing yogurt
Number of subjects: 30
Study 36697840 — intervention group
Group type: COMPARATOR
Intervention: Natural yogurt
Number of subjects: 30
Study 36697929 — intervention group
Group type: EXPERIMENTAL
Intervention: Mi Puente (MP)
Number of subjects: 536
Study 36697929 — intervention group
Group type: COMPARATOR
Intervention: Usual Care (UC)
Number of subjects: 536
Study 36698062 — intervention group
Group type: EXPERIMENTAL
Intervention: 24-h ambulatory BP monitoring (ABPM)
Number of subjects: 27
Study 36698062 — intervention group
Group type: EXPERIMENTAL
Intervention: Home BP monitoring (HBPM)
Number of subjects: 27
Study 36698062 — intervention group
Group type: COMPARATOR
Intervention: Clinic-based monitoring
Number of subjects: 27
Study 36698062 — intervention group
Group type: COMPARATOR
Intervention: BP kiosk in clinics or pharmacies
Number of subjects: 27
Study 36698064 — intervention group
Group type: EXPERIMENTAL
Intervention: Longitudinal data from 35 variables collected over 6 exam visits for 15 years
Number of subjects: 3539
Study 36698064 — intervention group
Group type: EXPERIMENTAL
Intervention: Longitudinal data
Number of subjects: 3539
Study 36698093 — intervention group
Group type: EXPERIMENTAL
Intervention: Standardised child records with increased psychosocial focus
Number of subjects: 12
Study 36698135 — intervention group
Group type: EXPERIMENTAL
Intervention: High neutralizing antibody (NAb) titers at days 37, 97, and 187 after symptom onset
Number of subjects: 47
Study 36698135 — intervention group
Group type: EXPERIMENTAL
Intervention: Peak viral load during admission
Number of subjects: 47
Study 36698168 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based tablet-based BCI intervention
Number of subjects: 20
Study 36698168 — intervention group
Group type: COMPARATOR
Intervention: Clinic-based tablet-based BCI intervention
Number of subjects: 20
Study 36698174 — intervention group
Group type: EXPERIMENTAL
Intervention: TCU© intervention (seven sessions over 2 months via Zoom)
Number of subjects: 60
Study 36698174 — intervention group
Group type: COMPARATOR
Intervention: SUPPORT© control condition (three sessions over 2 months via Zoom)
Number of subjects: 60
Study 36698194 — intervention group
Group type: EXPERIMENTAL
Intervention: Tobacco cessation pharmacotherapy (varenicline) paired with behavioral support
Number of subjects: 208
Study 36698197 — intervention group
Group type: EXPERIMENTAL
Intervention: blended therapist-assisted eMBCT
Number of subjects: 0
Study 36698197 — intervention group
Group type: EXPERIMENTAL
Intervention: unguided individual eMBCT
Number of subjects: 0
Study 36698197 — intervention group
Group type: COMPARATOR
Intervention: care as usual (CAU)
Number of subjects: 0
Study 36698207 — intervention group
Group type: EXPERIMENTAL
Intervention: Pemetrexed (Alvopem)
Number of subjects: 199
Study 36698210 — intervention group
Group type: EXPERIMENTAL
Intervention: Chess-based cognitive remediation training
Number of subjects: 90
Study 36698210 — intervention group
Group type: EXPERIMENTAL
Intervention: Implicit computer-based habit-modifying training
Number of subjects: 90
Study 36698210 — intervention group
Group type: COMPARATOR
Intervention: Standard smoking cessation group therapy
Number of subjects: 90
Study 36698416 — intervention group
Group type: EXPERIMENTAL
Intervention: PET/CT evaluation
Number of subjects: 61
Study 36698447 — intervention group
Group type: EXPERIMENTAL
Intervention: Cleansing gel containing salicylic acid 2%, zinc gluconate 0.2% and lipohydroxy acid 0.05%
Number of subjects: 51
Study 36698741 — intervention group
Group type: EXPERIMENTAL
Intervention: Shared medical appointments (SMAs) every 3 months over a 12-month study period
Number of subjects: 20
Study 36698741 — intervention group
Group type: EXPERIMENTAL
Intervention: Shared medical appointments (SMAs)
Number of subjects: 20
Study 36698743 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse AMIE for Echo Show (6 months)
Number of subjects: 42
Study 36698743 — intervention group
Group type: COMPARATOR
Intervention: Nurse AMIE for Echo Show (3 months after a 3 month delay)
Number of subjects: 42
Study 36698743 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse AMIE for Echo Show
Number of subjects: 42
Study 36698795 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-care and lifestyle interventions (spending time in nature)
Number of subjects: 1138
Study 36698795 — intervention group
Group type: EXPERIMENTAL
Intervention: Mental/emotional state assessment
Number of subjects: 1138
Study 36698795 — intervention group
Group type: EXPERIMENTAL
Intervention: Well-being assessment (WHO-5)
Number of subjects: 1138
Study 36698795 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-efficacy assessment (GSE-3)
Number of subjects: 1138
Study 36698862 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcranial alternating current stimulation (tACS) combined with sound stimulation
Number of subjects: 87